Head-to-head · WeighScore
9amHealth vs Primary Clinic (Direct GLP)
The verdict
9amHealth takes it — 71.3/100 to 65.5/100.
9amHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 9amHealth (join9am.com) is a cardiometabolic telehealth platform offering whole-body care including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | 9amHealth | Primary Clinic (Direct GLP) |
|---|---|---|
| WeighScore | 71.3/100 | 65.5/100 |
| Grade | C | C |
| Scorecard rank | #93 | #219 |
| Semaglutide | $149/mo (plus a separate fee, brand-name) | $85/mo (0.25-0.75 mg band, membership required, compounded) |
| Tirzepatide | Not disclosed | $133/mo (1.25-2.5 mg band, membership required, compounded) |
| Coverage | Coverage not published | 10 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #93 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
- $149/month membership or free when covered by insurance
- Membership includes specialists, labs, devices, and medications
- Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
- Helps navigate insurance approvals; employer and state-plan partnerships
Where it loses points
- Medication coverage and GLP-1 access depend on insurance and BMI criteria
- State availability not enumerated on the public site
- Branded GLP-1s can be costly without insurance coverage
- Pricing for medications not transparently listed
Graded #219 · C
Strengths
- Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
- GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
- Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
- Routine labs and thousands of medications included in membership — no surprise bills
- Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide
Where it loses points
- The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
- Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labelled starting dose
- The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.